The Research Tax Credit (RTC) is a generous incentive program that rewards companies of any size for conducting research activities in the United States. The credit is a dollar for dollar reduction of federal taxes owed. The majority of states also offer a similar incentive based on the federal criteria. Explore DST Advisory Group’s specific services to learn how we can support your claims process.
Industries we work with
Historically, many companies fail to make an RTC claim because they falsely assume that the program is restricted to “High Tech” companies. The fact is that virtually any company may have qualified research activities (QRAs) at any given time. In general, if some of your staff are engaged in solving technological problems for which a solution is not readily apparent, there is a good chance that the work they are doing is fully or partially eligible. Here are some of the industries we have supported in successful R&D Tax Credit claims.
Automotive
Parts and components manufacturing, fuel efficiency technologies, composite materials, EV battery technologies
Electronics
Semiconductor development, designing new microchips, enhanced sensor capability, control system development, new electronic interfaces
Casting & Foundries
Alloy formulation, reduction of slag inclusion, shrinkage techniques, elimination of cracking, gating or baffle system development
Food Science Technology & Processing
Recipe formulation, product development, shelf-life, cleanliness methods, scale-up processes
Automation & Robotics
Industry 4.0, integrating sensors or robotics for assembly, RFID or wireless communication, autonomous robots
Agriculture
New crop varietals, new pesticides and insecticides, automated or PLC picking systems or irrigation systems
Construction
New or improved building and construction materials, manufacturing processes, material recycling, emission reduction techniques, alternative source materials, lean manufacturing approaches
Biotechnology & Medical Device
NPD, device hardware prototyping, pre-clinical or clinical trials, FDA or regulatory changes
